Fairvalue-Calculator Fairvalue-Calculator
EN DE

clearvise AG (ABO) Fair Value & Analysis

Utilities · DE · Market cap €99.5M

Price€1.22
Fair Value€0.5700
Upside-53.3%
Quality95/100
Evidence: Medium Range €0.3600 – €0.7800

Fair value as of: Jun 25, 2026

Analysis

clearvise AG (ABO) currently trades at €1.22, while our model-based Fair Value estimate is €0.5700 — implying the stock looks roughly 53.3% overvalued today. We read business quality at 95/100 (high quality), in the Utilities sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

clearvise AG operates as an independent electricity producer from renewable energies in Europe. Its operational portfolio consists of wind and solar parks, and a biogas plant in four countries with an installed capacity of approximately 352 MW. The company was formerly known as ABO Invest AG and changed its name to clearvise AG in 2020. clearvise AG was founded in 2010 and is based in Frankfurt am Main, Germany.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is clearvise AG (ABO) undervalued?
As of Jun 25, 2026, our model estimates a fair value of €0.5700 versus a price of €1.22 — about −53% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ABO?
Our 21-model fair value for clearvise AG is €0.5700 (as of Jun 25, 2026), built from audited fundamentals. The current price is €1.22.
What is the quality score of ABO?
clearvise AG has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.